Reconsideration of macrophage and dendritic cell classification

Anticancer Research

Volumn 32, Issue 6, 2012, Pages 2257-2261

  Kadowaki, Takeshi ^a   Shimada, Misato ^a   Inagawa, Hiroyuki ^a,b,c   Kohchi, Chie ^a,b   Hirashima, Mitsuomi ^a   Soma, Gen Ichiro ^a,c,d  

^a KAGAWA UNIVERSITY   (Japan)

^b Research and Development Department Macrophi Inc   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

^d TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Classification; Dendritic cell; Macrophage; Marker; pDC; Review

Indexed keywords

CD86 ANTIGEN; COLONY STIMULATING FACTOR 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

CELL DIFFERENTIATION; CELL MATURATION; CELL STIMULATION; CELL SUBPOPULATION; CELL TYPE; CYTOKINE PRODUCTION; DENDRITIC CELL; INFLAMMATION; MACROPHAGE; MACROPHAGE ACTIVATION; MAST CELL; MONOCYTE; NEUTROPHIL; PHENOTYPE; PRIORITY JOURNAL; SHORT SURVEY; CLASSIFICATION; CYTOLOGY; HUMAN; IMMUNOLOGY; REVIEW;

CELL DIFFERENTIATION; DENDRITIC CELLS; HUMANS; MACROPHAGES;

EID: 84864546439     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (27)

1. Benoit M, Desnues B and Mege JL: Macrophage polarization in bacterial infections. J Immunol 181 : 3733-3739, 2008.
2. Mosser DM and Edwards JP: Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969, 2008.
3. Manrique SZ, Correa MA, Hoelzinger DB, Dominguez AL, Mirza N, Lin HH, Stein-Streilein J, Gordon S and Lustgarten J: Foxp3-positive macrophages display immunosuppressive properties and promote tumor growth. J Exp Med 208: 1485-1499, 2011.
4. Solinas G, Germano G, Mantovani A and Allavena P: Tumor-associated macrophages (TAM) as major players of the cancerrelated inflammation. J Leuk Biol 86: 1065-1073, 2009.
5. Mantovani A, Sozzani S, Locati M, Allavena P and Sica A: Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555, 2002.
6. Kurahara H, Shinchi H, Mataki Y, Maemura K, Noma H, Kubo F, Sakoda M, Ueno S, Natsugoe S and Takao S: Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surgi Res 167: e211-219, 2011.
7. Nagaraj S, Schrum AG, Cho HI, Celis E and Gabrilovich DI: Mechanism of T-cell tolerance induced by myeloid-derived suppressor cells. J Immunol 184: 3106-3116, 2010.
8. Kusmartsev S, Nagaraj S and Gabrilovich DI: Tumor-associated CD8+ T-cell tolerance induced by bone marrow-derived immature myeloid cells. J Immunol 175 : 4583-4592, 2005.
9. Gabrilovich DI, Velders MP, Sotomayor EM and Kast WM: Mechanism of immune dysfunction in cancer mediated by immature Gr- 1 + myeloid cells. J Immunol 166 : 5398-5406, 2001.
10. Fleetwood AJ, Dinh H, Cook AD, Hertzog PJ and Hamilton JA: GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. J Leuk Biol 86: 411-421, 2009.
11. Kuroda E, Ho V, Ruschmann J, Antignano F, Hamilton M, Rauh MJ, Antov A, Flavell RA, Sly LM and Krystal G: SHIP represses the generation of IL-3-induced M2 macrophages by inhibiting IL-4 production from basophils. J Immunol 183: 3652-3660, 2009.
12. Gordon S, Hamann J, Lin HH and Stacey M: F4/80 and the related adhesion-GPCRs. Eur J Immunol 41: 2472-2476, 2011.
13. Kadowaki T, Arikawa T, Shinonaga R, Oomizu S, Inagawa H, Soma G, Niki T and Hirashima M: Galectin-9 signaling prolongs survival in murine lung-cancer by inducing macrophages to differentiate into plasmacytoid dendritic cell-like macrophages. Clin Immunol 142: 296-307, 2012.
14. Bender A, Sapp M, Schuler G, Steinman RM and Bhardwaj N: Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Meth 196: 121-135, 1996.
15. Landi A, Babiuk LA and van Drunen Littel-van den Hurk S: Dendritic cells matured by a prostaglandin E2- containing cocktail can produce high levels of IL-12p70 and are more mature and Th1-biased than dendritic cells treated with TNF-α or LPS. Immunobiol 216: 649-662, 2011.
16. Dai SY, Nakagawa R, Itoh A, Murakami H, Kashio Y, Abe H, Katoh S, Kontani K, Kihara M, Zhang SL, Hata T, Nakamura T, Yamauchi A and Hirashima M: Galectin-9 induces maturation of human monocyte-derived dendritic cells. J Immunol 175: 2974-2981, 2005.
17. Ribechini E, Greifenberg V, Sandwick S and Lutz MB: Subsets, expansion and activation of myeloid-derived suppressor cells. Med Microbiol Immunol 199: 273-281, 2010.
18. Cao W and Liu YJ: Opn: key regulator of pDC interferon production. Nat Immunol 7 : 441-443, 2006.
19. Kawai T, Sato S, Ishii KJ, Coban C, Hemmi H, Yamamoto M, Terai K, Matsuda M, Inoue J, Uematsu S, Takeuchi O and Akira S: Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 5: 1061-1068, 2004.
20. Kolumam GA, Thomas S, Thompson LJ, Sprent J and Murali- Krishna K: Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 202 : 637-650, 2005.
21. Wenzel J, Worenkamper E, Freutel S, Henze S, Haller O, Bieber T and Tuting T: Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus. J Pathol 205: 435-442, 2005.
22. Zhu J, Huang X and Yang Y: A critical role for type I IFN-dependent NK cell activation in innate immune elimination of adenoviral vectors in vivo . Mol Ther 16 : 1300-1307, 2008.
23. Matta BM, Castellaneta A and Thomson AW: Tolerogenic plasmacytoid DC. Eur J Immunol 40 : 2667-2676, 2010.
24. Naik SH, Corcoran LM and Wu L: Development of murine plasmacytoid dendritic cell subsets. Immunol Cell Biol 83 : 563-570, 2005.
25. Nobumoto A, Oomizu S, Arikawa T, Katoh S, Nagahara K, Miyake M, Nishi N, Takeshita K, Niki T, Yamauchi A and Hirashima M: Galectin-9 expands unique macrophages exhibiting plasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice. Clin Immunol 130: 322-330, 2009.
26. Sasajima J, Mizukami Y, Sugiyama Y, Nakamura K, Kawamoto T, Koizumi K, Fujii R, Motomura W, Sato K, Suzuki Y, Tanno S, Fujiya M, Sasaki K, Shimizu N, Karasaki H, Kono T, Kawabe J, Ii M, Yoshiara H, Kamiyama N, Ashida T, Bardeesy N, Chung DC and Kohgo Y: Transplanting normal vascular proangiogenic cells to tumor-bearing mice triggers vascular remodeling and reduces hypoxia in tumors. Cancer Res 70 : 6283-6292, 2010.
27. Ogiku M, Kono H, Hara M, Tsuchiya M and Fujii H: Interleukin-17A plays a pivotal role in polymicrobial sepsis according to studies using IL-17A knockout mice. J Surgi Res 174: 281-291, 2010.